Abstract
Developing countries often present a dichotomous health care system, where patients may be treated in either public or private institutions that differ substantially in terms of level of access to diagnostic and therapeutic procedures. Herein, we present the first report of this comprehensive study to assess real-world data in non-small cell lung cancer (NSCLC) patients treated in the private health care in Brazil.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
